Dr. Ghesani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Gustave L Levy Pl
MC 150C
New York, NY 10029Phone+1 212-241-5774
Summary
- Dr. Nasrin Ghesani is a nuclear medicine physician in New York, NY. She received her medical degree from Government Medical College Gujurat and has been in practice 24 years. She is experienced in positron emission tomography, differential diagnosis, emission-computed tomography, fluorodeoxyglucose f18, and radiopharmaceuticals.
Education & Training
University of Pennsylvania Health SystemResidency, Nuclear Medicine, 2000 - 2001
Frankford Hospitals Program AInternship, Transitional Year, 1999 - 2000
Drexel University College of Medicine/Hahnemann University HospitalResidency, Nuclear Medicine, 1997 - 1999
Government Medical College GujuratClass of 1993
Certifications & Licensure
NY State Medical License 2018 - 2026
NJ State Medical License 2001 - 2025
PA State Medical License 1997 - 2001
American Board of Nuclear Medicine Nuclear Medicine
Certification Board of Nuclear CardiologyNuclear Cardiology
Clinical Trials
- Study of [F 18]HX4 Positron Emission Tomography (PET) as a Tool to Detect Hypoxia in Tumors Start of enrollment: 2010 Feb 01
- Novel Gallium 68 Citrate in Orthopedic Infections Start of enrollment: 2017 Mar 06
Publications & Presentations
PubMed
- Pretreatment Liquid Biopsy and Clinicopathologic Features in HPV-Associated Oropharyngeal Squamous Cell Carcinoma.Peter V Cooke, Susmita Chennareddy, Daniel O Kraft, Catharine Kappauf, Austin S Lam
JAMA Otolaryngology-- Head & Neck Surgery. 2025-03-13 - Evolving Paradigms in Lung Cancer: Latest Trends in Diagnosis, Management, and Radiopharmaceuticals.Busra Cangut, Rahman Akinlusi, Ava Mohseny, Nasrin Ghesani, Munir Ghesani
Seminars in Nuclear Medicine. 2025-03-01 - Does enzalutamide related PSMA upregulation affect outcomes of lutetium-177 PSMA radioligand therapy?Turgut Bora Cengiz, Raksha Kulkarni, Matteo Novello, Anthony Hafez, Somali Gavane
Urologia. 2024-08-01
Professional Memberships
- Member
- Society of Nuclear MedicineMember
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
